Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL4886009

CN(C)c1ccc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 9/20 0.58
KMT2A Q03164 8/20 0.58
MEN1 O00255 6/20 0.58
POLB P06746 5/20 0.58
RAB9A P51151 4/20 0.58
LMNA P02545 4/20 0.58
HTT P42858 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
NPSR1 Q6W5P4 4/20 0.58
BCHE P06276 3/20 0.58
NPC1 O15118 3/20 0.58
BLM P54132 3/20 0.58
MAPT P10636 3/20 0.58
THRB P10828 3/20 0.58
MAPK1 P28482 2/20 0.58
RECQL P46063 2/20 0.58
PKM P14618 1/20 0.58
SYNJ2 O15056 1/20 0.47
MLNR O43193 1/20 0.47
SYNJ1 O43426 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4886012 1.00 ACHE (0.58) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4878927 0.92 ACHE (0.55) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4882821 0.92 ACHE (0.49) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4878919 0.92 ACHE (0.55) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4882827 0.92 ACHE (0.49) ACHEKMT2AMEN1POLBRAB9A
SCHEMBL14007198 0.87 ACHE (0.74) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4884099 0.82 BCHE (0.43) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4884115 0.82 BCHE (0.43) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4878037 0.81 NSD2 (0.44) ACHEKMT2AMEN1POLBRAB9A
Trifluoromethanesulfonic Acid SCHEMBL4882455 0.80 AR (0.47) ACHEKMT2AMEN1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS ACHE 3641/4885KMT2A 944/4885MEN1 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.